Oct. 22, 2021 — Pfizer says its vaccine for kids is 90% efficient at stopping COVID-19 infections.

The Pfizer vaccine for teenagers ages 5 to 11 is 10 micrograms, roughly one-third of the dose given to adolescents and adults.

In knowledge introduced to the FDA forward of the company’s evaluate of its pictures for kids, the corporate described the interim outcomes of two ongoing research testing the security and effectiveness of its 10-microgram pictures.

The vaccine effectiveness knowledge comes from a research of greater than 2,000 youngsters ages 5 to 11. Two-thirds of the youngsters have been randomly assigned to obtain a child-sized dose of the Pfizer-BioNTech vaccine, whereas the opposite third was sorted into the placebo group.

The research bought underway because the Delta variant turned dominant around the globe. As of the primary week of October, 16 members within the placebo group had gotten a symptomatic, lab-confirmed COVID-19 an infection, in contrast with simply three who caught COVID within the vaccinated group.

Based on the corporate’s evaluation of its personal research, unwanted effects seen within the research have been practically all delicate. The commonest facet impact reported was ache on the web site of the shot. Children within the group that acquired the vaccine additionally had fatigue, complications, fever, and chills at larger charges than have been seen within the placebo group. These have been most typical after the second dose. Some pores and skin reactions have been seen within the research, like itching and rashes, however these have been largely delicate and went away inside a number of days.

Children additionally might have swollen lymph nodes after their vaccinations, as adults typically do, however these reactions have been short-term.

One youngster developed a tic, a recurring involuntary muscle twitch or vocal sound, that got here one week after their second dose of the vaccine. It was judged by research investigators to be associated to the vaccine. The corporate says it was going away by the point the research was being printed.

Reassuringly, no instances of coronary heart irritation referred to as myocarditis have been discovered within the research. Myocarditis is uncommon and short-term, but it surely requires hospital care.  The best charges of myocarditis have been seen in males youthful than 30.  That group has a threat of about 11 instances for each 100,000 doses given, in response to a current research within the New England Journal of Drugs.